113 results
Page 4 of 6
8-K
EX-99.1
3z38l e11d
30 Sep 20
T2 Biosystems Announces BARDA Exercise of Contract Option 1 Valued at $10.5 Million
1:15pm
8-K
63bamemgb987s wv
30 Sep 20
T2 Biosystems Announces BARDA Exercise of Contract Option 1 Valued at $10.5 Million
1:15pm
PRE 14A
lvny8 stj3
15 Jun 20
Preliminary proxy
4:00pm
424B5
5jxxl4rh
10 Mar 20
Prospectus supplement for primary offering
12:00am
8-K
EX-10.2
v7qocpyjllnx5
9 Jan 20
T2 Biosystems Appoints Industry Veteran John Sperzel as Chief Executive Officer
4:46pm
8-K
EX-99.1
8xi6km z11ku
20 Nov 19
T2 Biosystems Announces Granting ofCE-Mark for T2Resistanceā¢ Panel
7:45am
8-K
d2wvxjbx1
10 Sep 19
Entry into a Material Definitive Agreement
4:00pm
8-K
EX-99.2
8n58kstqb8dre w9ye
1 Aug 19
T2 Biosystems Reports Second Quarter 2019 Financial Results and Provides Corporate Update
4:32pm
8-K
EX-10.2
n4svwjr 6ap
30 Jul 19
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.1
8bf vr8cr7
30 Jul 19
Entry into a Material Definitive Agreement
4:43pm